Acute myelomonocytic leukemia, in relapse is a hematological malignancy characterized by the proliferation of myelomonocytic cells in the bone marrow and peripheral blood. This condition is clinically significant as it indicates a return of the disease after a period of remission, necessitating prompt and accurate diagnosis for effective treatment. The ICD-10 Code C92.52 facilitates precise documentation, billing, and public health reporting, ensuring that healthcare providers can track and manage this serious condition effectively.
ICD-10 Code C92.52 represents Acute myelomonocytic leukemia, in relapse, a subtype of acute myeloid leukemia characterized by the presence of myeloblasts and monoblasts in the blood and bone marrow. This code should be used when documenting a patient's return of symptoms or disease progression after initial treatment, ensuring accurate billing and continuity of care in clinical documentation.
Acute myelomonocytic leukemia, in relapse is caused by genetic mutations leading to uncontrolled proliferation of myelomonocytic cells. The disease can progress rapidly, resulting in severe complications such as anemia, thrombocytopenia, and increased susceptibility to infections, necessitating immediate medical intervention.
ICD-10 Code C92.52 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is crucial for both acute and chronic care settings, ensuring that the patient's condition is accurately recorded and managed throughout their treatment journey.
In SOAP notes, ICD-10 Code C92.52 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Acute myelomonocytic leukemia, in relapse. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Acute myelomonocytic leukemia, in relapse requires urgent medical attention, often necessitating hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C92.52 is essential for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 85027 | Complete blood count with differential. |
| 36415 | Collection of venous blood by venipuncture. |
| 85041 | Blood count, automated, with leukocyte differential. |
| 88305 | Pathology examination of tissue, including bone marrow biopsy. |
Common Questions About Using ICD-10 Code C92.52 for Acute myelomonocytic leukemia, in relapse
What are the common symptoms of Acute myelomonocytic leukemia, in relapse?
Common symptoms include fatigue, fever, easy bruising, and recurrent infections. Patients may also experience weight loss and night sweats, indicating disease progression.
How is Acute myelomonocytic leukemia, in relapse treated?
Treatment typically involves chemotherapy, supportive care, and possibly stem cell transplantation. Antibiotics may be administered to prevent or treat infections.
When should ICD-10 Code C92.52 be used?
This code should be used when documenting a patient's relapse of Acute myelomonocytic leukemia after a period of remission, ensuring accurate clinical and billing records.
What is the importance of accurate coding for Acute myelomonocytic leukemia, in relapse?
Accurate coding is crucial for appropriate treatment planning, reimbursement, and tracking of disease prevalence and outcomes in public health.
Clinical Notes
SOAP notes
DAP notes
AI medical notes